Qiagen's Q2 Revenues Rise 7 Percent, Aided by Currency | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Qiagen reported after the close of the market Monday that its second-quarter revenues increased 7 percent, or 1 percent on a constant exchange rate basis, "amid continued weak economic conditions."

The firm reported total sales of $282.2 million for the three-month period ended June 30, compared to $262.7 million for the second quarter of 2010. It beat analysts' consensus estimate of $279.4 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: role for RNA splicing in genetic variation, and more.

An advocacy group sues the US Food and Drug Administration over redactions of information about advisory committee members, Stat News reports.

Mexico is trying to lure young genomics researchers back home with their own labs, Science reports.

A molecular autopsy has aided a woman's search for why sudden cardiac death has stalked her family, the Wall Street Journal reports.